Vinnova Planeringsbidrag

Inicure has been granted support from VINNOVA Planeringsbidrag to improve our EIC Transition proposal. Inicure is coordinating a consortium for collaboration between LIOS, Queen Mary University of London and Swansea University for a joint programme to characterise and mature Inicure's candidate therapies to boost the innate immune system as a novel therapy to cure resistant infections, in a joint project called iCURE.

The EIC Transition application will be completed and submitted in mid September 2025.